| 000 | 01797 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516121217.0 | ||
| 264 | 0 | _c20131119 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1742-1241 | ||
| 024 | 7 |
_a10.1111/ijcp.12075 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGriffiths, T R L | |
| 245 | 0 | 0 |
_aCurrent perspectives in bladder cancer management. _h[electronic resource] |
| 260 |
_bInternational journal of clinical practice _cMay 2013 |
||
| 300 |
_a435-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Intravesical |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBiomedical Technology _xtrends |
| 650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCystectomy _xmethods |
| 650 | 0 | 4 |
_aCystoscopy _xmethods |
| 650 | 0 | 4 |
_aDiagnostic Imaging _xtrends |
| 650 | 0 | 4 |
_aHealth Promotion _xorganization & administration |
| 650 | 0 | 4 |
_aHematuria _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymph Node Excision _xinstrumentation |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aNephrectomy _xmethods |
| 650 | 0 | 4 |
_aOrgan Sparing Treatments _xmethods |
| 650 | 0 | 4 | _aPalliative Care |
| 650 | 0 | 4 | _aPrimary Health Care |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aRadiotherapy _xinstrumentation |
| 650 | 0 | 4 | _aReferral and Consultation |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aUreter _xsurgery |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xetiology |
| 773 | 0 |
_tInternational journal of clinical practice _gvol. 67 _gno. 5 _gp. 435-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ijcp.12075 _zAvailable from publisher's website |
| 999 |
_c22249718 _d22249718 |
||